000			02232 a2200613 4500
005			20250517132425.0
264		0	_c20170821
008			201708s 0 0 eng d
022			_a1468-2060
024	7		_a10.1136/annrheumdis-2016-210236 _2doi
040			_aNLM _beng _cNLM
100	1		_aCoghlan, John Gerry
245	0	0	_aInitial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial. _h[electronic resource]
260			_bAnnals of the rheumatic diseases _cJul 2017
300			_a1219-1227 p. _bdigital
500			_aPublication Type: Journal Article; Randomized Controlled Trial
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntihypertensive Agents _xtherapeutic use
650	0	4	_aDisease Progression
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Therapy, Combination
650	0	4	_aEdema _xchemically induced
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypertension, Pulmonary _xdrug therapy
650	0	4	_aLupus Erythematosus, Systemic _xcomplications
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMixed Connective Tissue Disease _xcomplications
650	0	4	_aPhenylpropionates _xtherapeutic use
650	0	4	_aPhosphodiesterase 5 Inhibitors _xtherapeutic use
650	0	4	_aPyridazines _xtherapeutic use
650	0	4	_aScleroderma, Systemic _xcomplications
650	0	4	_aTadalafil _xtherapeutic use
700	1		_aGaliè, Nazzareno
700	1		_aBarberà, Joan Albert
700	1		_aFrost, Adaani E
700	1		_aGhofrani, Hossein-Ardeschir
700	1		_aHoeper, Marius M
700	1		_aKuwana, Masataka
700	1		_aMcLaughlin, Vallerie V
700	1		_aPeacock, Andrew J
700	1		_aSimonneau, Gérald
700	1		_aVachiéry, Jean-Luc
700	1		_aBlair, Christiana
700	1		_aGillies, Hunter
700	1		_aMiller, Karen L
700	1		_aHarris, Julia H N
700	1		_aLangley, Jonathan
700	1		_aRubin, Lewis J
773	0		_tAnnals of the rheumatic diseases _gvol. 76 _gno. 7 _gp. 1219-1227
856	4	0	_uhttps://doi.org/10.1136/annrheumdis-2016-210236 _zAvailable from publisher's website
999			_c26743509 _d26743509